Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.12 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.37.
Market Cap
8.12T
Revenue
4.59T
Profits
201.13B
PE Ratio
40.37
Profit Margin
4.39%
Dividend Yield
0.44%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 862.82B | 2.02% | 2,007,554 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 531.56B | -0.23% | 2,620,185 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 358.34B | 0.63% | 2,268,796 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 346.21B | 0.33% | 3,851,141 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 285.79B | -0.32% | 1,450,948 | 60.44B |
| 6 | NVS | Novartis AG | 279.16B | -0.75% | 1,630,904 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 276.57B | 0.54% | 4,591,537 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 209.66B | 1.02% | 13,559,576 | 50.57B |
| 9 | AMGN | Amgen Inc. | 177.15B | -1.05% | 856,119 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 168.64B | -2.41% | 2,088,984 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 165.33B | 1.39% | 2,774,926 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 148.33B | -6.94% | 2,596,765 | 10.58B |
| 13 | PFE | Pfizer Inc. | 146.53B | 0.12% | 23,972,561 | 63.32B |
| 14 | ABT | Abbott Laboratories | 143.25B | -2.47% | 10,016,638 | 45.13B |
| 15 | DHR | Danaher Corporation | 117.76B | -2.79% | 4,471,467 | 24.78B |
| 16 | CVS | CVS Health Corporation | 117.67B | 1.84% | 7,155,590 | 405.62B |
| 17 | BMY | Bristol-Myers Squibb Company | 113.35B | -1.17% | 4,681,291 | 48.48B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 110.28B | 1.09% | 672,375 | 12.22B |
| 19 | SYK | Stryker Corporation | 108.52B | -0.74% | 1,576,301 | 25.27B |
| 20 | SNY | Sanofi | 103.27B | -1.33% | 3,673,947 | 54.60B |
| 21 | GSK | GSK plc | 100.25B | -0.97% | 2,484,672 | 43.29B |
| 22 | MDT | Medtronic plc | 96.19B | -1.62% | 6,349,002 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 93.89B | -2.74% | 1,085,538 | 76.39B |
| 24 | MCK | McKesson Corporation | 87.63B | -0.96% | 1,033,032 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 82.61B | 0.61% | 1,080,594 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 79.41B | -0.94% | 9,725,574 | 20.61B |
| 27 | CI | The Cigna Group | 76.70B | 0.66% | 839,276 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 71.63B | -1.51% | 563,203 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 51.94B | -0.67% | 3,136,698 | 28.48B |
| 30 | MDLN | Medline Inc. | 50.88B | -2.00% | 4,693,261 | 29.14B |
| 31 | COR | Cencora, Inc. | 50.66B | -0.27% | 1,526,326 | 328.68B |
| 32 | ARGX | argenx SE | 49.10B | 2.34% | 386,556 | 4.74B |
| 33 | EW | Edwards Lifesciences Corporation | 44.74B | -2.83% | 2,787,345 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 42.77B | -0.57% | 1,134,514 | 250.74B |
| 35 | TEVA | Teva Pharmaceutical Industries Limited | 42.13B | 1.26% | 3,402,628 | 17.35B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 41.71B | -5.59% | 399,790 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 39.83B | -3.25% | 1,957,459 | 22.23B |
| 38 | HLN | Haleon plc | 39.64B | -1.48% | 9,618,168 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.28B | -2.81% | 558,936 | 4.29B |
| 40 | ONC | BeOne Medicines AG | 34.58B | -0.34% | 178,108 | 5.74B |
| 41 | WAT | Waters Corporation | 34.36B | -1.44% | 604,010 | 3.77B |
| 42 | HUM | Humana Inc. | 33.26B | 0.74% | 1,516,010 | 137.20B |
| 43 | ZTS | Zoetis Inc. | 32.54B | -6.28% | 10,779,996 | 9.53B |
| 44 | A | Agilent Technologies, Inc. | 31.78B | -2.74% | 1,021,318 | 7.07B |
| 45 | ALC | Alcon Inc. | 30.84B | -0.78% | 2,106,041 | 10.63B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.18B | 0.11% | 838,420 | - |
| 47 | RPRX | Royalty Pharma plc | 29.57B | 1.12% | 1,424,859 | 2.44B |
| 48 | BIIB | Biogen Inc. | 29.11B | 1.91% | 759,258 | 9.94B |
| 49 | IQV | IQVIA Holdings Inc. | 29.07B | -2.53% | 882,856 | 16.63B |
| 50 | RMD | ResMed Inc. | 28.95B | -3.48% | 930,945 | 5.54B |
| 51 | NTRA | Natera, Inc. | 28.52B | 2.52% | 1,343,097 | 2.50B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 28.29B | -2.03% | 3,463,181 | 20.98B |
| 53 | CNC | Centene Corporation | 27.71B | 0.29% | 3,463,371 | 178.33B |
| 54 | VEEV | Veeva Systems Inc. | 25.97B | -4.42% | 1,246,045 | 3.20B |
| 55 | PHG | Koninklijke Philips N.V. | 25.91B | -1.30% | 1,148,555 | 20.34B |
| 56 | UTHR | United Therapeutics Corporation | 24.31B | 1.39% | 158,117 | 3.17B |
| 57 | BNTX | BioNTech SE | 23.50B | -1.26% | 443,331 | 3.23B |
| 58 | INSM | Insmed Incorporated | 22.88B | 4.13% | 5,142,698 | 819.56M |
| 59 | DXCM | DexCom, Inc. | 22.79B | -2.56% | 2,253,900 | 4.82B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.79B | -1.03% | 445,847 | 3.22B |
| 61 | MTD | Mettler-Toledo International Inc. | 22.08B | -2.81% | 138,284 | 4.09B |
| 62 | ILMN | Illumina, Inc. | 21.60B | 0.61% | 1,244,305 | 4.39B |
| 63 | DGX | Quest Diagnostics Incorporated | 20.91B | 0.81% | 302,833 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 20.85B | 0.08% | 251,589 | 14.14B |
| 65 | MRNA | Moderna, Inc. | 20.82B | -3.44% | 18,944,627 | 2.23B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.60B | 0.77% | 2,443,968 | 13.31M |
| 67 | INCY | Incyte Corporation | 19.99B | 1.52% | 838,048 | 5.36B |
| 68 | STE | STERIS plc | 19.85B | -2.42% | 504,964 | 5.83B |
| 69 | VTRS | Viatris Inc. | 19.69B | -1.51% | 7,751,714 | 14.56B |
| 70 | THC | Tenet Healthcare Corporation | 16.46B | 0.38% | 489,982 | 21.46B |
| 71 | GMAB | Genmab A/S | 16.06B | -0.74% | 2,020,378 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 15.53B | -2.48% | 1,304,453 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.22B | -0.60% | 593,395 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.60B | -1.51% | 309,274 | 998.25M |
| 75 | SMMT | Summit Therapeutics Inc. | 14.56B | 3.76% | 2,895,681 | - |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.05B | -0.80% | 520,701 | 4.44B |
| 77 | RGC | Regencell Bioscience Holdings Limited | 13.60B | -6.08% | 90,654 | - |
| 78 | SOLV | Solventum Corporation | 12.78B | 0.53% | 1,062,562 | 8.26B |
| 79 | DVA | DaVita Inc. | 12.74B | -0.07% | 521,840 | 13.84B |
| 80 | GH | Guardant Health, Inc. | 12.73B | 0.32% | 1,089,956 | 1.08B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 12.71B | -3.68% | 1,686,283 | 579.96M |
| 82 | PEN | Penumbra, Inc. | 12.68B | 0.03% | 190,859 | 1.45B |
| 83 | SNN | Smith & Nephew plc | 12.51B | -2.22% | 1,075,970 | 6.16B |
| 84 | EXEL | Exelixis, Inc. | 12.41B | 2.55% | 2,349,404 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | -0.88% | 850,054 | 1.06B |
| 86 | MEDP | Medpace Holdings, Inc. | 11.92B | -1.55% | 240,687 | 2.68B |
| 87 | FMS | Fresenius Medical Care AG | 11.80B | -0.91% | 618,697 | 22.32B |
| 88 | ALGN | Align Technology, Inc. | 11.68B | -3.37% | 598,675 | 4.10B |
| 89 | COO | The Cooper Companies, Inc. | 11.59B | -0.98% | 876,682 | 4.15B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | -2.51% | 178,488 | 1.13B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 11.28B | -0.64% | 2,081,515 | 3.85B |
| 92 | BTSG | BrightSpring Health Services, Inc. | 11.26B | -0.15% | 1,400,673 | 13.65B |
| 93 | RVTY | Revvity, Inc. | 11.15B | -1.29% | 901,018 | 2.90B |
| 94 | AXSM | Axsome Therapeutics, Inc. | 11.10B | -0.75% | 438,154 | 708.24M |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.02B | -6.68% | 4,568,710 | 4.89B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.80B | 5.50% | 1,459,881 | 622.01M |
| 97 | PODD | Insulet Corporation | 10.60B | -0.71% | 825,100 | 2.90B |
| 98 | GMED | Globus Medical, Inc. | 10.51B | -0.64% | 1,482,931 | 3.10B |
| 99 | EHC | Encompass Health Corporation | 10.39B | -1.30% | 311,938 | 6.07B |
| 100 | UHS | Universal Health Services, Inc. | 10.21B | -0.81% | 410,320 | 17.76B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.20B | -2.39% | 1,371,547 | 3.24B |
| 102 | ENSG | The Ensign Group, Inc. | 9.81B | -1.27% | 433,961 | 5.27B |
| 103 | ABVX | ABIVAX Société Anonyme | 9.71B | -0.88% | 556,874 | 5.37M |
| 104 | MOH | Molina Healthcare, Inc. | 9.60B | -0.89% | 540,833 | 43.10B |
| 105 | MASI | Masimo Corporation | 9.36B | 0.21% | 627,242 | 1.56B |
| 106 | CYTK | Cytokinetics, Incorporated | 9.33B | -2.48% | 2,008,639 | 105.82M |
| 107 | ICLR | ICON Public Limited Company | 9.19B | -3.31% | 456,258 | 8.10B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 9.17B | -0.31% | 368,894 | 7.46M |
| 109 | KRYS | Krystal Biotech, Inc. | 9.13B | 1.34% | 246,607 | 417.30M |
| 110 | BAX | Baxter International Inc. | 9.04B | -2.72% | 4,080,951 | 11.32B |
| 111 | TEM | Tempus AI, Inc. | 8.84B | -1.26% | 5,805,793 | 1.36B |
| 112 | IBRX | ImmunityBio, Inc. | 8.52B | -4.41% | 11,329,280 | 140.98M |
| 113 | CRL | Charles River Laboratories International, Inc. | 8.27B | -3.36% | 282,809 | 4.03B |
| 114 | NUVL | Nuvalent, Inc. | 8.26B | -0.68% | 144,729 | - |
| 115 | GKOS | Glaukos Corporation | 7.95B | 1.36% | 353,123 | 551.35M |
| 116 | HSIC | Henry Schein, Inc. | 7.86B | -2.51% | 1,098,152 | 13.38B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 7.85B | 3.38% | 958,506 | 1.40B |
| 118 | PCVX | Vaxcyte, Inc. | 7.72B | 0.88% | 800,967 | - |
| 119 | ATR | AptarGroup, Inc. | 7.64B | -1.12% | 353,233 | 3.87B |
| 120 | TECH | Bio-Techne Corporation | 7.48B | -1.24% | 1,520,727 | 1.21B |
| 121 | KYMR | Kymera Therapeutics, Inc. | 7.01B | -1.06% | 263,963 | 51.48M |
| 122 | HQY | HealthEquity, Inc. | 6.99B | -2.46% | 304,358 | 1.31B |
| 123 | HIMS | Hims & Hers Health, Inc. | 6.90B | 5.66% | 30,765,052 | 2.35B |
| 124 | QGEN | Qiagen N.V. | 6.80B | -0.51% | 1,196,497 | 2.10B |
| 125 | SYRE | Spyre Therapeutics, Inc. | 6.67B | 2.35% | 716,138 | - |
| 126 | BRKR | Bruker Corporation | 6.65B | -1.09% | 1,606,263 | 3.46B |
| 127 | RGEN | Repligen Corporation | 6.65B | -4.54% | 665,941 | 763.34M |
| 128 | OSCR | Oscar Health, Inc. | 6.59B | 2.67% | 5,539,309 | 13.30B |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.59B | 3.10% | 263,293 | 74.06M |
| 130 | BIO | Bio-Rad Laboratories, Inc. | 6.57B | -3.44% | 180,244 | 2.59B |
| 131 | GRFS | Grifols, S.A. | 6.54B | -2.35% | 596,060 | 8.58B |
| 132 | MIRM | Mirum Pharmaceuticals, Inc. | 6.40B | -2.02% | 229,396 | 569.61M |
| 133 | PTCT | PTC Therapeutics, Inc. | 6.37B | 4.21% | 2,219,729 | 827.11M |
| 134 | APGE | Apogee Therapeutics, Inc. | 6.32B | 1.90% | 330,867 | - |
| 135 | LNTH | Lantheus Holdings, Inc. | 6.22B | 2.60% | 536,025 | 1.55B |
| 136 | CNTA | Centessa Pharmaceuticals plc | 6.13B | - | 506,423 | 15.00M |
| 137 | CGON | CG Oncology, Inc. | 6.12B | -0.33% | 310,807 | 5.07M |
| 138 | CELC | Celcuity Inc. | 6.11B | -3.59% | 387,341 | - |
| 139 | TGTX | TG Therapeutics, Inc. | 6.06B | -0.19% | 1,731,600 | 700.35M |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.01B | -6.89% | 651,608 | 217.17M |
| 141 | BLTE | Belite Bio, Inc | 5.99B | -1.76% | 36,242 | - |
| 142 | ALKS | Alkermes plc | 5.93B | 1.74% | 838,562 | 1.56B |
| 143 | IMVT | Immunovant, Inc. | 5.86B | -0.52% | 704,969 | - |
| 144 | COGT | Cogent Biosciences, Inc. | 5.81B | -2.17% | 488,834 | - |
| 145 | SRRK | Scholar Rock Holding Corporation | 5.78B | -0.25% | 531,154 | - |
| 146 | TFX | Teleflex Incorporated | 5.77B | -1.98% | 427,679 | 2.13B |
| 147 | BLCO | Bausch + Lomb Corporation | 5.72B | -0.80% | 419,524 | 5.10B |
| 148 | CHE | Chemed Corporation | 5.53B | -1.48% | 97,950 | 2.54B |
| 149 | CORT | Corcept Therapeutics Incorporated | 5.52B | -1.64% | 455,740 | 769.10M |
| 150 | AVTR | Avantor, Inc. | 5.47B | -3.67% | 3,549,236 | 6.55B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.39B | -1.26% | 453,752 | 7.50M |
| 152 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | 0.04% | 4,890,422 | 1.11B |
| 153 | CRSP | CRISPR Therapeutics AG | 5.24B | -0.95% | 822,952 | 4.10M |
| 154 | PACS | PACS Group, Inc. | 5.17B | -2.02% | 428,012 | 5.29B |
| 155 | STVN | Stevanato Group S.p.A. | 4.98B | - | 272,693 | 1.39B |
| 156 | LEGN | Legend Biotech Corporation | 4.78B | -8.02% | 1,641,089 | 1.03B |
| 157 | DOCS | Doximity, Inc. | 4.74B | -1.15% | 2,132,108 | 637.78M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.71B | -0.61% | 127,599 | 1.34M |
| 159 | BLLN | BillionToOne, Inc. | 4.62B | 7.96% | 697,369 | 354.54M |
| 160 | LQDA | Liquidia Corporation | 4.57B | 21.54% | 4,874,779 | 288.07M |
| 161 | NAMS | NewAmsterdam Pharma Company N.V. | 4.57B | 2.61% | 1,757,750 | 22.57M |
| 162 | CAI | Caris Life Sciences, Inc. | 4.50B | -1.36% | 2,385,015 | 907.29M |
| 163 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.48B | -0.61% | 214,803 | 754.05M |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.48B | 0.86% | 102,078 | 274.48M |
| 165 | MANE | Veradermics, Incorporated | 4.46B | 2.08% | 212,016 | - |
| 166 | SHC | Sotera Health Company | 4.43B | -1.55% | 810,481 | 1.19B |
| 167 | RDNT | RadNet, Inc. | 4.43B | -2.81% | 1,554,252 | 2.14B |
| 168 | HNGE | Hinge Health, Inc. | 4.29B | -1.00% | 751,616 | 646.34M |
| 169 | AMRX | Amneal Pharmaceuticals, Inc. | 4.09B | -2.95% | 915,491 | 3.05B |
| 170 | TVTX | Travere Therapeutics, Inc. | 4.01B | 1.29% | 1,547,835 | 536.20M |
| 171 | ORKA | Oruka Therapeutics, Inc. | 3.93B | 1.68% | 633,973 | - |
| 172 | NVST | Envista Holdings Corporation | 3.92B | -0.62% | 2,391,096 | 2.81B |
| 173 | LIVN | LivaNova PLC | 3.86B | -2.17% | 525,585 | 1.43B |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.83B | -3.43% | 269,536 | 787.85M |
| 175 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.81B | -3.50% | 877,799 | 18.07M |
| 176 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.80B | - | 2,688,597 | 588.99M |
| 177 | WAY | Waystar Holding Corp. | 3.80B | -7.34% | 1,009,904 | 1.16B |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 3.73B | -2.81% | 1,088,515 | 1.10B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.71B | -2.42% | 567,626 | - |
| 180 | TLX | Telix Pharmaceuticals Limited | 3.68B | 1.50% | 130,982 | 803.79M |
| 181 | VKTX | Viking Therapeutics, Inc. | 3.64B | 0.10% | 1,315,940 | - |
| 182 | MMSI | Merit Medical Systems, Inc. | 3.62B | -0.88% | 380,654 | 1.54B |
| 183 | WRBY | Warby Parker Inc. | 3.61B | -0.58% | 2,734,734 | 890.57M |
| 184 | TWST | Twist Bioscience Corporation | 3.56B | 0.69% | 549,297 | 409.48M |
| 185 | OGN | Organon & Co. | 3.50B | -0.19% | 3,233,017 | 6.16B |
| 186 | ALHC | Alignment Healthcare, Inc. | 3.44B | -7.19% | 5,228,758 | 4.26B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.40B | 2.48% | 607,420 | 62.38M |
| 188 | ERAS | Erasca, Inc. | 3.24B | 2.87% | 2,586,821 | - |
| 189 | BEAM | Beam Therapeutics Inc. | 3.24B | 0.59% | 1,160,992 | 164.01M |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.19B | 3.17% | 541,041 | 2.23B |
| 191 | VCYT | Veracyte, Inc. | 3.18B | -1.42% | 483,197 | 541.74M |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.16B | -0.95% | 307,598 | 236.00M |
| 193 | MMED | MiniMed Group, Inc. | 3.16B | -2.77% | 351,726 | 2.99B |
| 194 | OPCH | Option Care Health, Inc. | 3.15B | -2.15% | 2,880,635 | 5.67B |
| 195 | ICUI | ICU Medical, Inc. | 3.11B | -1.51% | 245,859 | 2.16B |
| 196 | DNLI | Denali Therapeutics Inc. | 3.09B | -0.71% | 1,162,604 | - |
| 197 | ALMS | Alumis Inc. | 3.08B | 2.28% | 617,744 | 24.05M |
| 198 | BKD | Brookdale Senior Living Inc. | 3.03B | -1.77% | 2,324,577 | 3.00B |
| 199 | DYN | Dyne Therapeutics, Inc. | 2.98B | 2.56% | 604,966 | - |
| 200 | KLRA | Kailera Therapeutics, Inc. | 2.98B | 7.13% | 251,342 | - |
| 201 | NHC | National HealthCare Corporation | 2.98B | 0.91% | 52,035 | 1.53B |
| 202 | LFST | LifeStance Health Group, Inc. | 2.96B | -0.91% | 4,225,622 | 1.42B |
| 203 | ITGR | Integer Holdings Corporation | 2.95B | -1.38% | 173,486 | 1.86B |
| 204 | SUPN | Supernus Pharmaceuticals, Inc. | 2.88B | -3.84% | 395,790 | 776.83M |
| 205 | PRVA | Privia Health Group, Inc. | 2.83B | -2.56% | 606,694 | 2.25B |
| 206 | SLNO | Soleno Therapeutics, Inc. | 2.76B | -0.01% | 588,549 | 285.01M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.72B | -2.28% | 331,981 | - |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | 0.24% | 1,862,066 | 415.62M |
| 209 | IRON | Disc Medicine, Inc. | 2.64B | 1.44% | 214,589 | - |
| 210 | VERA | Vera Therapeutics, Inc. | 2.63B | 1.30% | 682,140 | - |
| 211 | GRAL | GRAIL, Inc. | 2.63B | -0.73% | 274,334 | 156.12M |
| 212 | IMNM | Immunome, Inc. | 2.63B | 3.30% | 591,687 | 6.94M |
| 213 | NKTR | Nektar Therapeutics | 2.62B | -5.15% | 982,269 | 55.63M |
| 214 | TXG | 10x Genomics, Inc. | 2.60B | -5.14% | 1,632,811 | 638.78M |
| 215 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | 1.19% | 719,966 | 670.00M |
| 216 | HTFL | HeartFlow, Inc. | 2.59B | 1.59% | 499,858 | 176.03M |
| 217 | CLDX | Celldex Therapeutics, Inc. | 2.55B | -4.47% | 494,893 | 865.00K |
| 218 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | -4.31% | 360,195 | 535.08M |
| 219 | KOD | Kodiak Sciences Inc. | 2.50B | -2.41% | 919,779 | - |
| 220 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -0.60% | 414,392 | 225.27M |
| 221 | RLAY | Relay Therapeutics, Inc. | 2.43B | -0.47% | 1,138,655 | 10.68M |
| 222 | HAE | Haemonetics Corporation | 2.43B | -5.26% | 597,592 | 1.33B |
| 223 | ELVN | Enliven Therapeutics, Inc. | 2.41B | -2.72% | 278,213 | - |
| 224 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | -1.12% | 387,995 | - |
| 225 | PBH | Prestige Consumer Healthcare Inc. | 2.39B | -3.92% | 480,316 | 1.10B |
| 226 | LMAT | LeMaitre Vascular, Inc. | 2.39B | -3.27% | 213,661 | 256.28M |
| 227 | DFTX | Definium Therapeutics, Inc. | 2.37B | -1.27% | 739,173 | - |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.32B | - | 696,447 | 3.37B |
| 229 | GRDN | Guardian Pharmacy Services, Inc. | 2.25B | -1.66% | 126,598 | 1.46B |
| 230 | HCM | HUTCHMED (China) Limited | 2.24B | -1.90% | 29,870 | 548.51M |
| 231 | TMDX | TransMedics Group, Inc. | 2.21B | -5.78% | 2,130,890 | 635.89M |
| 232 | ZLAB | Zai Lab Limited | 2.20B | 5.43% | 729,613 | 453.28M |
| 233 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | -0.27% | 3,376,663 | 3.68B |
| 234 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.18B | -0.58% | 1,760,564 | 885.72M |
| 235 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | -1.70% | 597,142 | 295.41M |
| 236 | NVCR | NovoCure Limited | 2.16B | 4.42% | 1,565,203 | 674.41M |
| 237 | AXGN | Axogen, Inc. | 2.15B | -3.73% | 537,592 | 238.11M |
| 238 | NBTX | Nanobiotix S.A. | 2.11B | 17.08% | 155,151 | 38.27M |
| 239 | SION | Sionna Therapeutics, Inc. | 2.10B | 5.22% | 422,124 | - |
| 240 | ESTA | Establishment Labs Holdings Inc. | 2.10B | -0.47% | 170,643 | 229.58M |
| 241 | TRVI | Trevi Therapeutics, Inc. | 2.07B | 0.76% | 647,334 | - |
| 242 | SRPT | Sarepta Therapeutics, Inc. | 2.06B | -2.33% | 1,669,451 | 2.18B |
| 243 | SEM | Select Medical Holdings Corporation | 2.04B | 0.15% | 583,631 | 5.52B |
| 244 | NTLA | Intellia Therapeutics, Inc. | 2.03B | 3.34% | 5,380,608 | 66.09M |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.03B | -3.83% | 2,209,750 | 52.04M |
| 246 | BHC | Bausch Health Companies Inc. | 2.03B | -5.48% | 907,616 | 10.53B |
| 247 | STOK | Stoke Therapeutics, Inc. | 2.02B | -1.52% | 240,287 | 32.08M |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 2.99% | 1,593,383 | 298.30M |
| 249 | PHVS | Pharvaris N.V. | 2.02B | 2.48% | 465,917 | - |
| 250 | AAPG | Ascentage Pharma Group International | 2.00B | 0.05% | 989 | 82.08M |
| 251 | TYRA | Tyra Biosciences, Inc. | 2.00B | -2.00% | 183,858 | - |
| 252 | OMCL | Omnicell, Inc. | 1.96B | -1.88% | 190,125 | 1.23B |
| 253 | INBX | Inhibrx Biosciences, Inc. | 1.96B | -0.38% | 971,622 | 1.30M |
| 254 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -0.15% | 898,450 | 7.47M |
| 255 | ANAB | AnaptysBio, Inc. | 1.94B | -2.70% | 324,800 | 234.60M |
| 256 | OCS | Oculis Holding AG | 1.94B | 0.20% | 533,325 | 1.51M |
| 257 | SNDX | Syndax Pharmaceuticals, Inc. | 1.93B | 1.54% | 1,427,233 | 217.17M |
| 258 | NEOG | Neogen Corporation | 1.92B | -2.65% | 620,968 | 870.56M |
| 259 | RAPP | Rapport Therapeutics, Inc. | 1.91B | 5.05% | 353,944 | 20.00M |
| 260 | MBX | MBX Biosciences, Inc. | 1.88B | -3.43% | 1,255,829 | - |
| 261 | MESO | Mesoblast Limited | 1.88B | -1.02% | 96,618 | 65.38M |
| 262 | MD | Pediatrix Medical Group, Inc. | 1.87B | -0.94% | 393,294 | 1.93B |
| 263 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -3.92% | 149,725 | 1.20B |
| 264 | ADMA | ADMA Biologics, Inc. | 1.85B | -2.39% | 4,394,871 | 509.86M |
| 265 | GENB | Generate Biomedicines, Inc. | 1.85B | 6.08% | 263,860 | 30.30M |
| 266 | ASTH | Astrana Health, Inc. | 1.84B | -4.43% | 244,987 | 3.53B |
| 267 | CAPR | Capricor Therapeutics, Inc. | 1.82B | 3.79% | 1,109,555 | 11.13M |
| 268 | SGRY | Surgery Partners, Inc. | 1.81B | -3.36% | 475,834 | 3.34B |
| 269 | AHG | Akso Health Group | 1.80B | 6.31% | 186,082 | 14.84M |
| 270 | ADUS | Addus HomeCare Corporation | 1.77B | -2.88% | 245,753 | 1.45B |
| 271 | HRMY | Harmony Biosciences Holdings, Inc. | 1.77B | -1.58% | 328,956 | 899.11M |
| 272 | PGNY | Progyny, Inc. | 1.76B | -5.06% | 1,863,121 | 1.29B |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | -5.57% | 419,685 | 923.71M |
| 274 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -0.45% | 10,080,374 | 66.41M |
| 275 | UFPT | UFP Technologies, Inc. | 1.75B | -1.49% | 168,076 | 608.85M |
| 276 | ZYME | Zymeworks Inc. | 1.75B | 0.17% | 572,027 | 81.26M |
| 277 | VRDN | Viridian Therapeutics, Inc. | 1.74B | 1.87% | 2,064,044 | 70.92M |
| 278 | PVLA | Palvella Therapeutics, Inc. | 1.73B | -0.39% | 142,625 | - |
| 279 | GLUE | Monte Rosa Therapeutics, Inc. | 1.73B | 5.78% | 710,955 | 42.95M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.73B | -3.40% | 727,143 | 367.10M |
| 281 | NRIX | Nurix Therapeutics, Inc. | 1.72B | 0.54% | 302,735 | 71.78M |
| 282 | QURE | uniQure N.V. | 1.71B | -2.02% | 1,538,792 | 18.09M |
| 283 | CLOV | Clover Health Investments, Corp. | 1.70B | 3.53% | 8,108,788 | 2.21B |
| 284 | VCEL | Vericel Corporation | 1.69B | -0.93% | 477,494 | 292.09M |
| 285 | ABCL | AbCellera Biologics Inc. | 1.67B | 4.10% | 9,455,586 | 75.13M |
| 286 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 0.40% | 295,020 | 66.05M |
| 287 | NUVB | Nuvation Bio Inc. | 1.66B | -0.52% | 1,388,394 | 143.05M |
| 288 | INVA | Innoviva, Inc. | 1.65B | -2.18% | 423,037 | 420.69M |
| 289 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | 0.88% | 1,231,062 | -665.00K |
| 290 | ARDX | Ardelyx, Inc. | 1.65B | -1.47% | 2,569,049 | 427.68M |
| 291 | ALMR | Alamar Biosciences, Inc. | 1.65B | 0.90% | 78,864 | 74.21M |
| 292 | IOVA | Iovance Biotherapeutics, Inc. | 1.64B | 1.52% | 14,300,237 | 285.61M |
| 293 | PRGO | Perrigo Company plc | 1.58B | -2.56% | 1,126,699 | 4.18B |
| 294 | VIR | Vir Biotechnology, Inc. | 1.57B | 2.25% | 811,086 | 65.50M |
| 295 | NVAX | Novavax, Inc. | 1.57B | -5.44% | 8,065,506 | 596.34M |
| 296 | IMTX | Immatics N.V. | 1.56B | 2.64% | 333,427 | 56.67M |
| 297 | URGN | UroGen Pharma Ltd. | 1.54B | 7.69% | 877,823 | 140.49M |
| 298 | HCSG | Healthcare Services Group, Inc. | 1.54B | -2.82% | 267,845 | 1.85B |
| 299 | PRCT | PROCEPT BioRobotics Corporation | 1.53B | 5.91% | 1,696,884 | 322.02M |
| 300 | AHCO | AdaptHealth Corp. | 1.50B | -0.04% | 641,850 | 3.29B |
| 301 | PGEN | Precigen, Inc. | 1.49B | 0.24% | 1,232,325 | 9.68M |
| 302 | BCAX | Bicara Therapeutics Inc. | 1.48B | -0.11% | 387,360 | - |
| 303 | ATAI | AtaiBeckley Inc. | 1.47B | -0.50% | 2,278,935 | 4.09M |
| 304 | PAHC | Phibro Animal Health Corporation | 1.47B | -9.38% | 635,865 | 1.50B |
| 305 | IMCR | Immunocore Holdings plc | 1.47B | -2.54% | 80,856 | 412.81M |
| 306 | DMRA | Damora Therapeutics, Inc. | 1.45B | -0.79% | 133,567 | - |
| 307 | ENOV | Enovis Corporation | 1.44B | -5.88% | 681,395 | 2.28B |
| 308 | ARDT | Ardent Health, Inc. | 1.43B | -0.99% | 208,722 | 6.43B |
| 309 | FTRE | Fortrea Holdings Inc. | 1.42B | -2.53% | 531,209 | 2.71B |
| 310 | HROW | Harrow, Inc. | 1.42B | -0.24% | 962,946 | 272.30M |
| 311 | AVAH | Aveanna Healthcare Holdings Inc. | 1.42B | -3.12% | 577,901 | 2.43B |
| 312 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.07% | 1,339,731 | 73.62M |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.42B | -1.54% | 361,030 | 2.50M |
| 314 | BHVN | Biohaven Ltd. | 1.39B | -6.69% | 944,597 | - |
| 315 | MPLT | MapLight Therapeutics, Inc. | 1.37B | 10.15% | 129,513 | - |
| 316 | STAA | STAAR Surgical Company | 1.37B | 3.41% | 389,660 | 239.44M |
| 317 | WVE | Wave Life Sciences Ltd. | 1.36B | -1.39% | 1,772,524 | 71.80M |
| 318 | MLTX | MoonLake Immunotherapeutics | 1.36B | 9.32% | 2,369,610 | - |
| 319 | PLSE | Pulse Biosciences, Inc. | 1.34B | 2.86% | 848,567 | 751.00K |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -2.15% | 153,351 | - |
| 321 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | 1.67% | 786,061 | - |
| 322 | ATRC | AtriCure, Inc. | 1.33B | -0.34% | 398,804 | 552.16M |
| 323 | GHRS | GH Research PLC | 1.32B | -0.82% | 60,719 | - |
| 324 | SVRA | Savara Inc. | 1.31B | -0.86% | 612,326 | - |
| 325 | CMPS | COMPASS Pathways plc | 1.30B | -2.52% | 1,757,846 | - |
| 326 | OLMA | Olema Pharmaceuticals, Inc. | 1.29B | -0.74% | 421,303 | - |
| 327 | INSP | Inspire Medical Systems, Inc. | 1.28B | 0.07% | 405,718 | 915.25M |
| 328 | TDOC | Teladoc Health, Inc. | 1.25B | -4.14% | 2,780,053 | 2.51B |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.25B | 1.71% | 125,079 | 83.72M |
| 330 | AVLN | Avalyn Pharma Inc. | 1.23B | 7.46% | 135,843 | - |
| 331 | JBIO | Jade Biosciences, Inc. | 1.22B | -3.91% | 293,584 | - |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.21B | 7.87% | 1,648,669 | 3.42B |
| 333 | ZBIO | Zenas BioPharma, Inc. | 1.21B | 3.16% | 222,916 | 10.00M |
| 334 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.20B | -3.81% | 3,222,409 | 204.73M |
| 335 | COLL | Collegium Pharmaceutical, Inc. | 1.20B | -2.33% | 273,632 | 796.33M |
| 336 | PNTG | The Pennant Group, Inc. | 1.20B | -4.16% | 226,540 | 1.02B |
| 337 | DBVT | DBV Technologies S.A. | 1.19B | 3.70% | 134,761 | 5.74M |
| 338 | EYPT | EyePoint, Inc. | 1.17B | 2.56% | 663,127 | 7.61M |
| 339 | AVNS | Avanos Medical, Inc. | 1.16B | - | 600,176 | 715.90M |
| 340 | WGS | GeneDx Holdings Corp. | 1.16B | -4.22% | 1,094,119 | 442.68M |
| 341 | AORT | Artivion, Inc. | 1.14B | -7.40% | 1,200,676 | 458.69M |
| 342 | CDNA | CareDx, Inc. | 1.13B | 0.25% | 207,709 | 412.82M |
| 343 | ALVO | Alvotech | 1.13B | 10.58% | 485,196 | 562.04M |
| 344 | NEO | NeoGenomics, Inc. | 1.13B | -3.29% | 1,001,233 | 745.97M |
| 345 | BFLY | Butterfly Network, Inc. | 1.12B | 2.52% | 2,110,169 | 102.92M |
| 346 | IART | Integra LifeSciences Holdings Corporation | 1.11B | 2.73% | 751,423 | 1.64B |
| 347 | IVA | Inventiva S.A. | 1.11B | 8.01% | 970,195 | 7.94M |
| 348 | NNNN | Anbio Biotechnology | 1.09B | -3.60% | 14,527 | 8.65M |
| 349 | EVO | Evotec SE | 1.09B | -0.81% | 43,110 | 859.03M |
| 350 | COAG | Hemab Therapeutics Holdings, Inc. | 1.08B | -2.47% | 160,604 | - |
| 351 | CNMD | CONMED Corporation | 1.08B | -2.53% | 273,002 | 1.37B |
| 352 | IRMD | IRADIMED CORPORATION | 1.07B | -2.66% | 37,202 | 86.28M |
| 353 | ATEC | Alphatec Holdings, Inc. | 1.07B | -7.71% | 3,226,625 | 787.08M |
| 354 | SEPN | Septerna, Inc. | 1.07B | -0.54% | 67,117 | 45.95M |
| 355 | BLFS | BioLife Solutions, Inc. | 1.07B | -1.04% | 117,529 | 101.66M |
| 356 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | -5.82% | 1,695,070 | 314.85M |
| 357 | MNKD | MannKind Corporation | 1.04B | -4.55% | 4,144,925 | 360.78M |
| 358 | OMER | Omeros Corporation | 1.04B | 1.84% | 512,748 | - |
| 359 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | 2.11% | 256,385 | 1.02B |
| 360 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.00B | 18.50% | 9,821,436 | 69.64M |
| 361 | AKTS | Aktis Oncology, Inc. | 1.00B | -2.69% | 79,948 | 6.50M |
| 362 | SANA | Sana Biotechnology, Inc. | 990.67M | 1.71% | 1,543,558 | - |
| 363 | INNV | InnovAge Holding Corp. | 988.16M | -3.83% | 433,928 | 949.17M |
| 364 | TNDM | Tandem Diabetes Care, Inc. | 985.45M | -7.11% | 2,240,615 | 1.03B |
| 365 | PHAT | Phathom Pharmaceuticals, Inc. | 975.00M | 0.95% | 408,541 | 204.89M |
| 366 | SLS | SELLAS Life Sciences Group, Inc. | 974.33M | 5.39% | 5,291,806 | - |
| 367 | DSGN | Design Therapeutics, Inc. | 966.21M | 8.79% | 404,665 | - |
| 368 | AGL | agilon health, inc. | 965.82M | 6.75% | 371,340 | 5.82B |
| 369 | XNCR | Xencor, Inc. | 963.84M | 1.09% | 344,642 | 97.36M |
| 370 | GDRX | GoodRx Holdings, Inc. | 961.84M | -2.74% | 1,386,832 | 787.89M |
| 371 | CRON | Cronos Group Inc. | 953.79M | 8.07% | 3,557,779 | 146.59M |
| 372 | SDGR | Schrödinger, Inc. | 950.07M | -3.16% | 1,218,686 | 254.91M |
| 373 | LBRX | LB Pharmaceuticals Inc | 936.26M | 2.13% | 39,404 | - |
| 374 | VOR | Vor Biopharma Inc. | 935.79M | 1.95% | 1,003,261 | - |
| 375 | DRTS | Alpha Tau Medical Ltd. | 935.54M | 24.91% | 4,427,100 | - |
| 376 | ABSI | Absci Corporation | 933.87M | 1.53% | 5,029,209 | 1.84M |
| 377 | NUTX | Nutex Health Inc. | 928.95M | -1.22% | 98,311 | 879.95M |
| 378 | ANNX | Annexon, Inc. | 926.53M | -0.62% | 1,185,000 | - |
| 379 | ORIC | ORIC Pharmaceuticals, Inc. | 926.48M | 1.13% | 628,566 | - |
| 380 | MGTX | MeiraGTx Holdings plc | 925.74M | 1.83% | 303,091 | 81.39M |
| 381 | PHAR | Pharming Group N.V. | 916.90M | -1.77% | 23,146 | 369.49M |
| 382 | USPH | U.S. Physical Therapy, Inc. | 914.19M | 1.32% | 158,782 | 787.69M |
| 383 | CGEM | Cullinan Therapeutics, Inc. | 907.74M | 1.51% | 617,614 | - |
| 384 | GERN | Geron Corporation | 901.34M | 1.08% | 23,611,995 | 196.12M |
| 385 | PCRX | Pacira BioSciences, Inc. | 887.49M | -2.57% | 291,239 | 734.86M |
| 386 | ANRO | Alto Neuroscience, Inc. | 873.16M | 2.68% | 236,918 | - |
| 387 | OMDA | Omada Health, Inc. | 872.70M | -0.94% | 984,028 | 283.30M |
| 388 | INMD | InMode Ltd. | 871.50M | -1.47% | 966,300 | 374.64M |
| 389 | TALK | Talkspace, Inc. | 867.12M | - | 1,294,765 | 228.87M |
| 390 | BVS | Bioventus Inc. | 867.09M | -1.14% | 241,532 | 576.30M |
| 391 | KURA | Kura Oncology, Inc. | 861.44M | 3.03% | 701,351 | 67.48M |
| 392 | JANX | Janux Therapeutics, Inc. | 861.10M | -0.39% | 403,534 | 13.73M |
| 393 | AURA | Aura Biosciences, Inc. | 859.91M | -1.37% | 185,866 | - |
| 394 | SPRY | ARS Pharmaceuticals, Inc. | 855.97M | -1.37% | 779,960 | 84.28M |
| 395 | ABUS | Arbutus Biopharma Corporation | 854.72M | - | 382,679 | 14.08M |
| 396 | TBPH | Theravance Biopharma, Inc. | 853.20M | -2.70% | 253,020 | 109.78M |
| 397 | CTMX | CytomX Therapeutics, Inc. | 846.83M | -2.26% | 1,690,074 | 35.54M |
| 398 | OPK | OPKO Health, Inc. | 845.70M | -1.75% | 867,155 | 581.12M |
| 399 | AZTA | Azenta, Inc. | 843.01M | -4.84% | 491,783 | 596.48M |
| 400 | EVMN | Evommune, Inc. | 841.39M | 1.92% | 526,801 | 10.00M |
| 401 | AMPH | Amphastar Pharmaceuticals, Inc. | 835.78M | -0.24% | 706,490 | 720.53M |
| 402 | BIOA | BioAge Labs, Inc. | 817.93M | 2.28% | 277,090 | 10.32M |
| 403 | ETON | Eton Pharmaceuticals, Inc. | 808.62M | -0.32% | 121,294 | 79.95M |
| 404 | ESPR | Esperion Therapeutics, Inc. | 805.76M | -0.32% | 15,184,831 | 418.24M |
| 405 | DRUG | Bright Minds Biosciences Inc. | 804.32M | -1.09% | 96,430 | - |
| 406 | ODTX | Odyssey Therapeutics, Inc. | 801.96M | 3.53% | 263,018 | 2.98M |
| 407 | SPTX | Seaport Therapeutics, Inc. | 794.89M | -6.60% | 282,117 | - |
| 408 | ALLO | Allogene Therapeutics, Inc. | 794.59M | 1.32% | 3,342,253 | 22.00K |
| 409 | SSII | SS Innovations International, Inc. | 789.76M | 2.07% | 29,973 | 42.48M |
| 410 | SGP | SpyGlass Pharma, Inc. | 782.18M | -0.04% | 9,090 | - |
| 411 | CERT | Certara, Inc. | 775.82M | -19.81% | 5,318,839 | 419.75M |
| 412 | CBLL | CeriBell, Inc. | 763.89M | -0.15% | 106,379 | 89.06M |
| 413 | RLMD | Relmada Therapeutics, Inc. | 763.59M | -0.55% | 596,293 | - |
| 414 | SLDB | Solid Biosciences Inc. | 744.99M | 4.13% | 605,425 | - |
| 415 | EHAB | Enhabit, Inc. | 706.14M | -0.04% | 224,251 | 1.06B |
| 416 | TENX | Tenax Therapeutics, Inc. | 694.76M | 1.20% | 686,343 | - |
| 417 | BWAY | BrainsWay Ltd. | 694.68M | -3.09% | 144,067 | 52.23M |
| 418 | QDEL | QuidelOrtho Corporation | 692.82M | -5.93% | 1,138,131 | 2.66B |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 691.34M | 0.41% | 1,237,339 | 8.37M |
| 420 | IRWD | Ironwood Pharmaceuticals, Inc. | 690.55M | -0.59% | 1,331,041 | 361.51M |
| 421 | HSTM | HealthStream, Inc. | 677.06M | -3.28% | 161,047 | 311.78M |
| 422 | TLRY | Tilray Brands, Inc. | 666.79M | 0.54% | 2,631,521 | 858.28M |
| 423 | CADL | Candel Therapeutics, Inc. | 659.43M | 7.78% | 3,002,583 | - |
| 424 | FBRX | Forte Biosciences, Inc. | 652.30M | 7.08% | 270,199 | - |
| 425 | GYRE | Gyre Therapeutics, Inc. | 650.57M | -4.69% | 38,186 | 117.05M |
| 426 | STRO | Sutro Biopharma, Inc. | 640.02M | -4.00% | 126,072 | 102.48M |
| 427 | TRAX | First Tracks Biotherapeutics, Inc. | 639.73M | -5.78% | 177,302 | - |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 639.03M | -2.88% | 1,507,692 | 122.29M |
| 429 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 629.06M | 2.61% | 223,496 | - |
| 430 | AVR | Anteris Technologies Global Corp. | 628.04M | -0.76% | 381,365 | 1.91M |
| 431 | KYTX | Kyverna Therapeutics, Inc. | 622.25M | 9.95% | 984,686 | - |
| 432 | ARVN | Arvinas, Inc. | 620.59M | -4.86% | 720,625 | 262.60M |
| 433 | PSNL | Personalis, Inc. | 610.52M | -2.51% | 912,123 | 64.52M |
| 434 | CRMD | CorMedix Inc. | 608.32M | -2.08% | 806,870 | 311.71M |
| 435 | CABA | Cabaletta Bio, Inc. | 607.36M | -3.99% | 4,040,793 | - |
| 436 | AGMB | AgomAb Therapeutics NV | 603.78M | 1.07% | 99,802 | - |
| 437 | ALT | Altimmune, Inc. | 600.08M | - | 2,177,474 | 41.00K |
| 438 | PRME | Prime Medicine, Inc. | 596.04M | 2.80% | 2,532,664 | 4.03M |
| 439 | CBIO | Crescent Biopharma, Inc. | 591.81M | -5.06% | 263,653 | 11.88M |
| 440 | PHR | Phreesia, Inc. | 583.33M | -5.60% | 433,130 | 480.59M |
| 441 | CSTL | Castle Biosciences, Inc. | 580.21M | -3.53% | 202,965 | 339.92M |
| 442 | DNA | Ginkgo Bioworks Holdings, Inc. | 567.67M | -2.69% | 1,129,224 | 151.40M |
| 443 | EIKN | Eikon Therapeutics, Inc. | 561.42M | 4.12% | 465,705 | - |
| 444 | CTKB | Cytek Biosciences, Inc. | 553.38M | -7.05% | 648,974 | 204.17M |
| 445 | FDMT | 4D Molecular Therapeutics, Inc. | 553.08M | 4.34% | 599,143 | 88.24M |
| 446 | NPCE | NeuroPace, Inc. | 551.02M | -11.55% | 342,485 | 99.99M |
| 447 | TCMD | Tactile Systems Technology, Inc. | 546.99M | -5.46% | 225,360 | 343.52M |
| 448 | STTK | Shattuck Labs, Inc. | 542.68M | 4.82% | 275,853 | 1.00M |
| 449 | AQST | Aquestive Therapeutics, Inc. | 540.64M | 0.69% | 1,037,387 | 44.55M |
| 450 | PROK | ProKidney Corp. | 540.51M | -3.76% | 1,075,723 | 893.00K |
| 451 | AVTX | Avalo Therapeutics, Inc. | 540.43M | -6.21% | 2,066,583 | 59.00K |
| 452 | VALN | Valneva SE | 535.73M | 12.88% | 104,068 | 205.07M |
| 453 | MDXG | MiMedx Group, Inc. | 531.74M | -0.83% | 1,127,535 | 389.42M |
| 454 | CLYM | Climb Bio, Inc. | 530.71M | -2.29% | 943,619 | - |
| 455 | CTNM | Contineum Therapeutics, Inc. | 527.93M | -2.68% | 69,526 | - |
| 456 | RGNX | REGENXBIO Inc. | 526.50M | -3.32% | 824,586 | 170.44M |
| 457 | ANL | Adlai Nortye Ltd. | 526.40M | -0.90% | 112,926 | 5.00M |
| 458 | SIBN | SI-BONE, Inc. | 520.53M | -4.12% | 1,090,359 | 200.93M |
| 459 | CERS | Cerus Corporation | 517.95M | -0.96% | 1,353,932 | 216.56M |
| 460 | CTEV | Claritev Corporation | 515.87M | 12.07% | 139,088 | 978.76M |
| 461 | TECX | Tectonic Therapeutic, Inc. | 514.56M | -5.97% | 307,875 | - |
| 462 | IMMX | Immix Biopharma, Inc. | 512.63M | -0.82% | 473,187 | - |
| 463 | PRTA | Prothena Corporation plc | 509.66M | -9.27% | 566,115 | 57.94M |
| 464 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 465 | OCGN | Ocugen, Inc. | 502.70M | -1.66% | 7,227,635 | 4.47M |
| 466 | KMDA | Kamada Ltd. | 497.12M | -0.94% | 50,185 | 180.46M |
| 467 | XOMA | XOMA Royalty Corporation | 497.01M | -0.43% | 51,163 | 52.15M |
| 468 | UPB | Upstream Bio, Inc. | 494.13M | -0.11% | 193,036 | 2.85M |
| 469 | SRTA | Strata Critical Medical, Inc. | 493.63M | 2.42% | 1,057,714 | 228.58M |
| 470 | PRLD | Prelude Therapeutics Incorporated | 490.82M | 0.41% | 257,704 | 12.14M |
| 471 | RIGL | Rigel Pharmaceuticals, Inc. | 484.01M | 0.46% | 165,944 | 299.77M |
| 472 | SGMT | Sagimet Biosciences Inc. | 481.66M | 1.17% | 599,992 | - |
| 473 | OVID | Ovid Therapeutics Inc. | 480.18M | -0.89% | 3,122,673 | 7.25M |
| 474 | ASMB | Assembly Biosciences, Inc. | 479.48M | 1.45% | 52,624 | 71.10M |
| 475 | EBS | Emergent BioSolutions Inc. | 478.81M | -2.32% | 352,205 | 676.80M |
| 476 | OFIX | Orthofix Medical Inc. | 476.17M | 1.12% | 176,636 | 825.37M |
| 477 | NGNE | Neurogene Inc. | 473.39M | -1.51% | 76,898 | 925.00K |
| 478 | FULC | Fulcrum Therapeutics, Inc. | 472.43M | 1.14% | 444,775 | 80.00M |
| 479 | LXEO | Lexeo Therapeutics, Inc. | 470.34M | 2.74% | 615,815 | - |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 463.21M | 0.54% | 35,549 | - |
| 481 | LYEL | Lyell Immunopharma, Inc. | 449.85M | -0.26% | 74,910 | 31.00K |
| 482 | ANGO | AngioDynamics, Inc. | 448.08M | -4.02% | 256,245 | 313.73M |
| 483 | FLGT | Fulgent Genetics, Inc. | 446.74M | -1.44% | 292,721 | 320.35M |
| 484 | CATX | Perspective Therapeutics, Inc. | 444.67M | 3.72% | 726,424 | 884.00K |
| 485 | ENTA | Enanta Pharmaceuticals, Inc. | 442.54M | -0.59% | 92,983 | 66.98M |
| 486 | ADCT | ADC Therapeutics SA | 441.99M | -0.71% | 770,968 | 79.18M |
| 487 | MNPR | Monopar Therapeutics Inc. | 441.95M | 3.88% | 123,261 | - |
| 488 | KIDS | OrthoPediatrics Corp. | 440.88M | -3.62% | 103,968 | 243.30M |
| 489 | ZURA | Zura Bio Limited | 440.25M | -3.13% | 644,882 | - |
| 490 | WEAV | Weave Communications, Inc. | 437.61M | -7.41% | 711,020 | 248.72M |
| 491 | PRTC | PureTech Health plc | 437.17M | 1.60% | 27,681 | 4.66M |
| 492 | BBNX | Beta Bionics, Inc. | 435.81M | 1.35% | 295,163 | 110.24M |
| 493 | IVVD | Invivyd, Inc. | 435.52M | 2.67% | 1,208,893 | 53.43M |
| 494 | AVIR | Atea Pharmaceuticals, Inc. | 435.35M | 0.18% | 90,276 | - |
| 495 | VSTM | Verastem, Inc. | 434.97M | 1.23% | 2,159,752 | 49.59M |
| 496 | EVH | Evolent Health, Inc. | 434.18M | -7.66% | 3,397,695 | 1.89B |
| 497 | AUTL | Autolus Therapeutics plc | 428.49M | 2.55% | 1,026,948 | 75.39M |
| 498 | CGC | Canopy Growth Corporation | 428.41M | 3.60% | 4,589,942 | 203.04M |
| 499 | PACB | Pacific Biosciences of California, Inc. | 427.08M | -2.48% | 3,637,007 | 160.03M |
| 500 | CCRN | Cross Country Healthcare, Inc. | 424.69M | -0.34% | 517,536 | 1.00B |